The Journal of Bone Oncology is a peer-reviewed international journal aimed at presenting basic, translational and clinical high-quality research related to bone and cancer.

As the first journal dedicated to cancer induced bone diseases, JBO welcomes original research articles, review articles, editorials and opinion pieces. Case reports will only be considered in exceptional circumstances and only when accompanied by a comprehensive review of the subject.

The areas covered by the journal include:

Bone metastases (pathophysiology, epidemiology, diagnostics, clinical features, prevention, treatment)

Preclinical models of metastasis

Bone microenvironment in cancer (stem cell, bone cell and cancer interactions)

Bone targeted therapy (pharmacology, therapeutic targets, drug development, clinical trials, side-effects, outcome research, health economics)

Cancer treatment induced bone loss (epidemiology, pathophysiology, prevention and management)

Bone imaging (clinical and animal, skeletal interventional radiology)

Bone biomarkers (clinical and translational applications)

Radiotherapy and radio-isotopes

Skeletal complications

Bone pain (mechanisms and management)

Orthopaedic cancer surgery

Primary bone tumours

Clinical guidelines

Multidisciplinary care

Keywords: bisphosphonate, bone, breast cancer, cancer, CTIBL, denosumab, metastasis, myeloma, osteoblast, osteoclast, osteooncology, osteo-oncology, prostate cancer, skeleton, tumour.

《Journal Of Bone Oncology》是一本由ELSEVIER出版商出版的专业医学期刊，刊期4 issues/year，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 3区，小类学科：肿瘤学 4区；在JCR（Journal Citation Reports）分区等级为Q2。该刊发文范围涵盖肿瘤学等领域，旨在及时、准确、全面地报道国内外肿瘤学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为4.491，平均审稿速度20 Weeks。